Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cysteine rich protein 1 pseudogene 4 (CRIP1P4) is classified as a pseudogene in the human genome. Unlike canonical protein-coding genes, pseudogenes are typically non-functional and do not produce active proteins. There is no evidence that CRIP1P4 encodes a biologically active protein, nor that it acts as a therapeutic target, disease biomarker, or has any relevance for drug action, safety, or efficacy. Its designation as a pseudogene reflects its status as a genomic sequence similar to cysteine rich protein 1 (CRIP1), but does not perform any known biological function[2][5][9]. This target is therefore not appropriate for drug discovery or therapeutic intervention, and if included as a target, it likely reflects a misinterpretation or incorrect annotation. If you intended cysteine rich protein 1 (CRIP1) itself—a functional coding gene—see entries for CRIP1 instead[4][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cysteine rich protein 1 pseudogene 4 (CRIP1P4).